Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact

Table of Contents

August 31, 2019 ;  104 (9)

Editorials

  • You have access
    Stem cell factor: the bridge between bone marrow adipocytes and hematopoietic cells
    Ziru Li, Ormond A. MacDougald
    Haematologica September 2019 104: 1689-1691; doi:10.3324/haematol.2019.224188
    • Disclosures and Contributions
  • You have access
    New potential players in hepcidin regulation
    Maxwell Chappell, Stefano Rivella
    Haematologica September 2019 104: 1691-1693; doi:10.3324/haematol.2019.224311
    • Disclosures and Contributions
  • You have access
    Ubiquitination is not omnipresent in myeloid leukemia
    Ramesh C. Nayak, Jose A. Cancelas
    Haematologica September 2019 104: 1694-1696; doi:10.3324/haematol.2019.224162
    • Disclosures and Contributions
  • You have access
    Six-packed antibodies punch better
    Christoph Rader, Adrian Wiestner
    Haematologica September 2019 104: 1696-1699; doi:10.3324/haematol.2019.224196
    • Disclosures and Contributions
  • You have access
    The secret afterlife of platelets
    Nicholas A. Arce, Renhao Li
    Haematologica September 2019 104: 1699-1701; doi:10.3324/haematol.2019.224170
    • Disclosures and Contributions

Perspective Article

  • Open Access
    Hemophilia A and B: molecular and clinical similarities and differences
    Giancarlo Castaman, Davide Matino
    Haematologica September 2019 104: 1702-1709; doi:10.3324/haematol.2019.221093
    • Castaman et al. Graphical Abstract
    • Disclosures and Contributions

Review Articles

  • Open Access
    Emerging disease-modifying therapies for sickle cell disease
    Marcus A. Carden, Jane Little
    Haematologica September 2019 104: 1710-1719; doi:10.3324/haematol.2018.207357
    • Carden et al. Graphical Abstract
    • Carden et al. Supplementary Appendix
    • Disclosures and Contributions
  • Open Access
    Targeting sickle cell disease root-cause pathophysiology with small molecules
    Yogen Saunthararajah
    Haematologica September 2019 104: 1720-1730; doi:10.3324/haematol.2018.207530
    • Saunthararajah Graphical Abstract
    • Disclosures and Contributions

Articles

  • Hematopoiesis

    • Open Access
      Bone marrow adipose tissue-derived stem cell factor mediates metabolic regulation of hematopoiesis
      Zengdi Zhang, Zan Huang, Brianna Ong, Chinmayi Sahu, Hu Zeng, Hai-Bin Ruan
      Haematologica September 2019 104: 1731-1743; doi:10.3324/haematol.2018.205856
      • Zhang et al. Graphical Abstract
      • Zhang et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiation
      Laura Crisafulli, Sharon Muggeo, Paolo Uva, Yulei Wang, Masayuki Iwasaki, Silvia Locatelli, Achille Anselmo, Federico S. Colombo, Carmelo Carlo-Stella, Michael L. Cleary, Anna Villa, Bernhard Gentner, Francesca Ficara
      Haematologica September 2019 104: 1744-1755; doi:10.3324/haematol.2018.198499
      • Crisafulli et al. Supplementary Appendix
      • Disclosures and Contributions
  • Iron Metabolism & its Disorders

    • Open Access
      Dimeric ferrochelatase bridges ABCB7 and ABCB10 homodimers in an architecturally defined molecular complex required for heme biosynthesis
      Nunziata Maio, Ki Soon Kim, Gregory Holmes-Hampton, Anamika Singh, Tracey A. Rouault
      Haematologica September 2019 104: 1756-1767; doi:10.3324/haematol.2018.214320
      • Maio et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia
      Jing Liu, Wei Liu, Yin Liu, Yang Miao, Yifan Guo, Haoyang Song, Fudi Wang, Hongyu Zhou, Tomas Ganz, Bing Yan, Sijin Liu
      Haematologica September 2019 104: 1768-1781; doi:10.3324/haematol.2018.209874
      • Liu et al. Graphical Abstract
      • Liu et al. Supplementary Appendix
      • Disclosures and Contributions
  • Myeloproliferative Neoplasms

    • Open Access
      Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
      Marie Robin, Liesbeth C. de Wreede, Christine Wolschke, Johannes Schetelig, Diderik-Jan Eikema, Maria Teresa Van Lint, Nina Simone Knelange, Dietrich Beelen, Arne Brecht, Dietger Niederwieser, Antonin Vitek, Wolfgang Bethge, Renate Arnold, Jürgen Finke, Liisa Volin, Ibrahim Yakoub-Agha, Arnon Nagler, Xavier Poiré, Hermann Einsele, Patrice Chevallier, Ernst Holler, Per Ljungman, Stephen Robinson, Alekxandar Radujkovic, Donal McLornan, Yves Chalandon, Nicolaus Kröger
      Haematologica September 2019 104: 1782-1788; doi:10.3324/haematol.2018.205211
      • Disclosures and Contributions
  • Chronic Myeloid Leukemia

    • Open Access
      De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
      Vera Magistroni, Mario Mauri, Deborah D’Aliberti, Caterina Mezzatesta, Ilaria Crespiatico, Miriam Nava, Diletta Fontana, Nitesh Sharma, Wendy Parker, Andreas Schreiber, David Yeung, Alessandra Pirola, Sara Readelli, Luca Massimino, Paul Wang, Praveen Khandelwal, Stefania Citterio, Michela Viltadi, Silvia Bombelli, Roberta Rigolio, Roberto Perego, Jacqueline Boultwood, Alessandro Morotti, Giuseppe Saglio, Dong-Wook Kim, Susan Branford, Carlo Gambacorti-Passerini, Rocco Piazza
      Haematologica September 2019 104: 1789-1797; doi:10.3324/haematol.2017.179937
      • Magistroni et al. Graphical Abstract
      • Magistroni et al. Supplementary Appendix
      • Disclosures and Contributions
  • Acute Myeloid Leukemia

    • Open Access
      Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience
      Ron Ram, Christof Scheid, Odelia Amit, Jens Markus Chemnitz, Yakir Moshe, Michael Hallek, Dominik Wolf, Irit Avivi, Udo Holtick
      Haematologica September 2019 104: 1798-1803; doi:10.3324/haematol.2018.203869
      • Ram et al. Supplementary Appendix
      • Disclosures and Contributions
  • Acute Lymphoblastic Leukemia

    • Open Access
      Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM
      Elizabeth C. Matheson, Huw Thomas, Marian Case, Helen Blair, Rosanna K. Jackson, Dino Masic, Gareth Veal, Chris Halsey, David R. Newell, Josef Vormoor, Julie A.E. Irving
      Haematologica September 2019 104: 1804-1811; doi:10.3324/haematol.2017.185975
      • Matheson et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
      Carmelo Rizzari, Claudia Lanvers-Kaminsky, Maria Grazia Valsecchi, Andrea Ballerini, Cristina Matteo, Joachim Gerss, Gudrun Wuerthwein, Daniela Silvestri, Antonella Colombini, Valentino Conter, Andrea Biondi, Martin Schrappe, Anja Moericke, Martin Zimmermann, Arend von Stackelberg, Christin Linderkamp, Michael C. Frühwald, Sabine Legien, Andishe Attarbaschi, Bettina Reismüller, David Kasper, Petr Smisek, Jan Stary, Luciana Vinti, Elena Barisone, Rosanna Parasole, Concetta Micalizzi, Massimo Zucchetti, Joachim Boos
      Haematologica September 2019 104: 1812-1821; doi:10.3324/haematol.2018.206433
      • Disclosures and Contributions
  • Non-Hodgkin Lymphoma

    • Open Access
      Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
      Blanca Gonzalez-Farre, Joan Enric Ramis-Zaldivar, Julia Salmeron-Villalobos, Olga Balagué, Verónica Celis, Jaime Verdu-Amoros, Ferran Nadeu, Constantino Sábado, Antonio Ferrández, Marta Garrido, Federico García-Bragado, María Dolores de la Maya, José Manuel Vagace, Carlos Manuel Panizo, Itziar Astigarraga, Mara Andrés, Elaine S. Jaffe, Elias Campo, Itziar Salaverria
      Haematologica September 2019 104: 1822-1829; doi:10.3324/haematol.2018.207928
      • Gonzalez-Farre et al. Supplementary Appendix
      • Disclosures and Contributions
  • Chronic Lymphocytic Leukemia

    • Open Access
      Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity
      Junyan Lu, Martin Böttcher, Tatjana Walther, Dimitrios Mougiakakos, Thorsten Zenz, Wolfgang Huber
      Haematologica September 2019 104: 1830-1840; doi:10.3324/haematol.2018.203067
      • Lu et al. Supplementary Appendix
      • Disclosures and Contributions
  • Cell Therapy & Immunotherapy

    • Open Access
      CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
      Simone C. Oostindie, Hilma J. van der Horst, Margaret A. Lindorfer, Erika M. Cook, Jillian C. Tupitza, Clive S. Zent, Richard Burack, Karl R. VanDerMeid, Kristin Strumane, Martine E. D. Chamuleau, Tuna Mutis, Rob N. de Jong, Janine Schuurman, Esther C. W. Breij, Frank J. Beurskens, Paul W. H. I. Parren, Ronald P. Taylor
      Haematologica September 2019 104: 1841-1852; doi:10.3324/haematol.2018.207266
      • Oostindie et al. Graphical Abstract
      • Oostindie et al. Supplementary Appendix
      • Disclosures and Contributions
  • Platelet Biology & its Disorders

    • Open Access
      CD45 expression discriminates waves of embryonic megakaryocytes in the mouse
      Isabel Cortegano, Natalia Serrano, Carolina Ruiz, Mercedes Rodríguez, Carmen Prado, Mario Alía, Andrés Hidalgo, Eva Cano, Belén de Andrés, María-Luisa Gaspar
      Haematologica September 2019 104: 1853-1865; doi:10.3324/haematol.2018.192559
      • Cortegano et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      Fatal dysfunction and disintegration of thrombin-stimulated platelets
      Oleg V. Kim, Tatiana A. Nevzorova, Elmira R. Mordakhanova, Anastasia A. Ponomareva, Izabella A. Andrianova, Giang Le Minh, Amina G. Daminova, Alina D. Peshkova, Mark S. Alber, Olga Vagin, Rustem I. Litvinov, John W. Weisel
      Haematologica September 2019 104: 1866-1878; doi:10.3324/haematol.2018.202309
      • Kim et al. Graphical Abstract
      • Kim et al. Supplementary Appendix
      • Disclosures and Contributions
    • Open Access
      A novel combinatorial technique for simultaneous quantification of oxygen radicals and aggregation reveals unexpected redox patterns in the activation of platelets by different physiopathological stimuli
      Dina Vara, Eugenia Cifuentes-Pagano, Patrick J. Pagano, Giordano Pula
      Haematologica September 2019 104: 1879-1891; doi:10.3324/haematol.2018.208819
      • Vara et al. Supplementary Appendix
      • Disclosures and Contributions
  • Hemostasis

    • Open Access
      Tspan18 is a novel regulator of the Ca2+ channel Orai1 and von Willebrand factor release in endothelial cells
      Peter J. Noy, Rebecca L. Gavin, Dario Colombo, Elizabeth J. Haining, Jasmeet S. Reyat, Holly Payne, Ina Thielmann, Adam B. Lokman, Georgiana Neag, Jing Yang, Tammy Lloyd, Neale Harrison, Victoria L. Heath, Chris Gardiner, Katharine M. Whitworth, Joseph Robinson, Chek Z. Koo, Alessandro Di Maio, Paul Harrison, Steven P. Lee, Francesco Michelangeli, Neena Kalia, G. Ed Rainger, Bernhard Nieswandt, Alexander Brill, Steve P. Watson, Michael G. Tomlinson
      Haematologica September 2019 104: 1892-1905; doi:10.3324/haematol.2018.194241
      • Noy et al. Supplementary Appendix
      • Disclosures and Contributions

Letters to the Editor

  • You have access
    Children with sickle cell anemia and APOL1 genetic variants develop albuminuria early in life
    Rima S. Zahr, Evadnie Rampersaud, Guolian Kang, Mitchell J. Weiss, Gang Wu, Robert L. Davis, Jane S. Hankins, Jeremie H. Estepp, Jeffrey Lebensburger
    Haematologica September 2019 104: e385-e387; doi:10.3324/haematol.2018.212779
    • Disclosures and Contributions
  • You have access
    Myelodysplastic syndrome-associated spliceosome gene mutations enhance innate immune signaling
    Daniel A. Pollyea, Chelsea Harris, Jennifer L. Rabe, Brenna R. Hedin, Lesly De Arras, Sigrid Katz, Emily Wheeler, Rafael Bejar, Matthew J. Walter, Craig T. Jordan, Eric M. Pietras, Scott Alper
    Haematologica September 2019 104: e388-e392; doi:10.3324/haematol.2018.214155
    • Pollyea et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Adult patients with de novo acute myeloid leukemia show a functional deregulation of redox balance at diagnosis which is correlated with molecular subtypes and overall survival
    Julie Mondet, Caroline Lo Presti, Catherine Garrel, Kristina Skaare, Clara Mariette, Sylvain Carras, Sophie Park, Martin Carré, Claude-Eric Bulabois, Lysiane Molina, Rémy Gressin, Anne Thiebaut, Stéphane Courby, Nuria Socoro-Yuste, Patrice Faure, Anne Mc Leer-Florin, Jean-Yves Cahn, Pascal Mossuz
    Haematologica September 2019 104: e393-e397; doi:10.3324/haematol.2018.206821
    • Mondet et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party
    Ali Bazarbachi, Myriam Labopin, Giorgia Battipaglia, Azedine Djabali, Jakob Passweg, Gerard Socié, Edouard Forcade, Didier Blaise, Patrice Chevallier, Corentin Orvain, Jan J. Cornelissen, William Arcese, Sylvain Chantepie, Khowla Hashaishi, Jean El Cheikh, Michael Medinger, Jordi Esteve, Arnon Nagler, Mohamad Mohty
    Haematologica September 2019 104: e398-e401; doi:10.3324/haematol.2018.211615
    • Bazarbachi et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia
    Stefanie V. Junk, Norman Klein, Sabine Schreek, Martin Zimmermann, Anja Möricke, Kirsten Bleckmann, Julia Alten, Elif Dagdan, Gunnar Cario, Christian P. Kratz, Martin Schrappe, Martin Stanulla
    Haematologica September 2019 104: e402-e405; doi:10.3324/haematol.2018.205849
    • Junk et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    A high definition picture of key genes and pathways mutated in pediatric follicular lymphoma
    Federica Lovisa, Andrea Binatti, Alessandro Coppe, Simona Primerano, Elisa Carraro, Marta Pillon, Marco Pizzi, Vincenza Guzzardo, Salvatore Buffardi, Fulvio Porta, Piero Farruggia, Raffaela De Santis, Pietro Bulian, Giuseppe Basso, Elena Lazzari, Emanuele S.G. d’Amore, Stefania Bortoluzzi, Lara Mussolin
    Haematologica September 2019 104: e406-e409; doi:10.3324/haematol.2018.211631
    • Lovisa et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines
    Tiziana D’Agaro, Antonella Zucchetto, Filippo Vit, Tamara Bittolo, Erika Tissino, Francesca Maria Rossi, Massimo Degan, Francesco Zaja, Pietro Bulian, Michele Dal Bo, Simone Ferrero, Marco Ladetto, Alberto Zamò, Valter Gattei, Riccardo Bomben
    Haematologica September 2019 104: e410-e414; doi:10.3324/haematol.2018.212811
    • DAgaro et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    A metabolic switch in proteasome inhibitor-resistant multiple myeloma ensures higher mitochondrial metabolism, protein folding and sphingomyelin synthesis
    Lenka Besse, Andrej Besse, Max Mendez-Lopez, Katerina Vasickova, Miroslava Sedlackova, Petr Vanhara, Marianne Kraus, Jürgen Bader, Renan B. Ferreira, Ronald K. Castellano, Brian K. Law, Christoph Driessen
    Haematologica September 2019 104: e415-e419; doi:10.3324/haematol.2018.207704
    • Besse et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma
    Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, Anna Jauch, Marc-Steffen Raab, Sandra Sauer, Jens Hillengass, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss
    Haematologica September 2019 104: e420-e423; doi:10.3324/haematol.2018.213041
    • Sachpekidis et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    The diagnostic performance of renal function-adjusted D-dimer testing in individuals suspected of having venous thromboembolism
    Vincent ten Cate, Markus Nagler, Marina Panova-Noeva, Lisa Eggebrecht, Natalie Arnold, Heidrun Lamparter, M Iris Hermanns, Hugo ten Cate, Martin H. Prins, Christine Espinola-Klein, Thomas Münzel, Karl J. Lackner, Philipp S. Wild, Jürgen H. Prochaska
    Haematologica September 2019 104: e424-e427; doi:10.3324/haematol.2018.213322
    • ten Cate et al. Supplementary Appendix
    • Disclosures and Contributions

Case Reports

  • You have access
    Compound heterozygosity in PKLR gene for a previously unrecognized intronic polymorphism and a rare missense mutation as a novel cause of severe pyruvate kinase deficiency
    Shruti Bagla, Kanta Bhambhani, Manisha Gadgeel, Steven Buck, Jian-Ping Jin, Yaddanapudi Ravindranath
    Haematologica September 2019 104: e428-e431; doi:10.3324/haematol.2018.214692
    • Bagla et al. Supplementary Appendix
    • Disclosures and Contributions
  • You have access
    Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm. A single-case report
    Katrine F. Iversen, Paw C. Holdgaard, Birgitte Preiss, Charlotte G. Nyvold, Torben Plesner
    Haematologica September 2019 104: e432-e433; doi:10.3324/haematol.2018.214635
    • Disclosures and Contributions
  • You have access
    Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia
    Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer
    Haematologica September 2019 104: e434-e437; doi:10.3324/haematol.2019.222588
    • Tausch et al. Supplementary Appendix
    • Disclosures and Contributions
Back to top
PreviousNext

In this issue

Haematologica: 104 (9)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Jump to

  • Editorials
  • Perspective Article
  • Review Articles
  • Articles
    • Hematopoiesis
    • Iron Metabolism & its Disorders
    • Myeloproliferative Neoplasms
    • Chronic Myeloid Leukemia
    • Acute Myeloid Leukemia
    • Acute Lymphoblastic Leukemia
    • Non-Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cell Therapy & Immunotherapy
    • Platelet Biology & its Disorders
    • Hemostasis
  • Letters to the Editor
  • Case Reports

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

 

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online